Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

A single mouse monoclonal antibody, E58 modulates multiple IgE epitopes on group 1 cedar pollen allergens.

Goldblum RM, Ning B, Judy BM, Holthauzen LM, van Bavel J, Kamijo A, Midoro-Horiuti T.

Mol Immunol. 2016 Jun;74:106-12. doi: 10.1016/j.molimm.2016.04.006. Epub 2016 May 9.

2.

A gold nanoparticle-linked glycoconjugate vaccine against Burkholderia mallei.

Gregory AE, Judy BM, Qazi O, Blumentritt CA, Brown KA, Shaw AM, Torres AG, Titball RW.

Nanomedicine. 2015 Feb;11(2):447-56. doi: 10.1016/j.nano.2014.08.005. Epub 2014 Sep 3.

3.

IgE antibodies to mountain cedar pollen predominantly recognize multiple conformational epitopes on Jun a 1.

Goldblum RM, Ning B, Endsley MA, Estes DM, Judy BM, van Bavel J, Midoro-Horiuti T.

J Allergy Clin Immunol. 2014 Oct;134(4):967-9.e7. doi: 10.1016/j.jaci.2014.05.009. Epub 2014 Jun 27. No abstract available.

4.

A Burkholderia pseudomallei outer membrane vesicle vaccine provides protection against lethal sepsis.

Nieves W, Petersen H, Judy BM, Blumentritt CA, Russell-Lodrigue K, Roy CJ, Torres AG, Morici LA.

Clin Vaccine Immunol. 2014 May;21(5):747-54. doi: 10.1128/CVI.00119-14. Epub 2014 Mar 26.

5.

A humanized mouse model of tuberculosis.

Calderon VE, Valbuena G, Goez Y, Judy BM, Huante MB, Sutjita P, Johnston RK, Estes DM, Hunter RL, Actor JK, Cirillo JD, Endsley JJ.

PLoS One. 2013 May 17;8(5):e63331. doi: 10.1371/journal.pone.0063331. Print 2013.

6.

Polysaccharide specific monoclonal antibodies provide passive protection against intranasal challenge with Burkholderia pseudomallei.

AuCoin DP, Reed DE, Marlenee NL, Bowen RA, Thorkildson P, Judy BM, Torres AG, Kozel TR.

PLoS One. 2012;7(4):e35386. doi: 10.1371/journal.pone.0035386. Epub 2012 Apr 17.

7.

Prophylactic application of CpG oligonucleotides augments the early host response and confers protection in acute melioidosis.

Judy BM, Taylor K, Deeraksa A, Johnston RK, Endsley JJ, Vijayakumar S, Aronson JF, Estes DM, Torres AG.

PLoS One. 2012;7(3):e34176. doi: 10.1371/journal.pone.0034176. Epub 2012 Mar 20.

8.

Protective antigens against glanders identified by expression library immunization.

Whitlock GC, Robida MD, Judy BM, Qazi O, Brown KA, Deeraksa A, Taylor K, Massey S, Loskutov A, Borovkov AY, Brown K, Cano JA, Torres AG, Estes DM, Sykes KF.

Front Microbiol. 2011 Nov 21;2:227. doi: 10.3389/fmicb.2011.00227. eCollection 2011.

9.

In vivo Bioluminescence Imaging of Burkholderia mallei Respiratory Infection and Treatment in the Mouse Model.

Massey S, Johnston K, Mott TM, Judy BM, Kvitko BH, Schweizer HP, Estes DM, Torres AG.

Front Microbiol. 2011 Aug 26;2:174. doi: 10.3389/fmicb.2011.00174. eCollection 2011.

10.

Development of reagents and assays for the detection of pathogenic Burkholderia species.

Qazi O, Rani M, Gnanam AJ, Cullen TW, Stead CM, Kensing H, McCaul K, Ngugi S, Prior JL, Lipka A, Nagy JM, Gregory CW, Judy BM, Harding SV, Titball RW, Sidhu SS, Trent MS, Kitto GB, Torres A, Estes DM, Iverson B, Georgiou G, Brown KA.

Faraday Discuss. 2011;149:23-36; discussion 63-77.

11.

Synthesis and in vitro Efficacy Studies of Silver Carbene Complexes on Biosafety Level 3 Bacteria.

Panzner MJ, Deeraksa A, Smith A, Wright BD, Hindi KM, Kascatan-Nebioglu A, Torres AG, Judy BM, Hovis CE, Hilliard JK, Mallett RJ, Cope E, Estes DM, Cannon CL, Leid JG, Youngs WJ.

Eur J Inorg Chem. 2009 May 1;2009(13):1739-1745.

12.

Protective response to subunit vaccination against intranasal Burkholderia mallei and B. pseudomallei challenge.

Whitlock GC, Deeraksa A, Qazi O, Judy BM, Taylor K, Propst KL, Duffy AJ, Johnson K, Kitto GB, Brown KA, Dow SW, Torres AG, Estes DM.

Procedia Vaccinol. 2010;2(1). doi: 10.1016/j.provac.2010.03.013.

13.

CD4+ T cells provide protection against acute lethal encephalitis caused by Venezuelan equine encephalitis virus.

Yun NE, Peng BH, Bertke AS, Borisevich V, Smith JK, Smith JN, Poussard AL, Salazar M, Judy BM, Zacks MA, Estes DM, Paessler S.

Vaccine. 2009 Jun 19;27(30):4064-73. doi: 10.1016/j.vaccine.2009.04.015. Epub 2009 May 3.

14.

Comparison of the in vitro and in vivo susceptibilities of Burkholderia mallei to Ceftazidime and Levofloxacin.

Judy BM, Whitlock GC, Torres AG, Estes DM.

BMC Microbiol. 2009 May 9;9:88. doi: 10.1186/1471-2180-9-88.

15.

Burkholderia mallei cellular interactions in a respiratory cell model.

Whitlock GC, Valbuena GA, Popov VL, Judy BM, Estes DM, Torres AG.

J Med Microbiol. 2009 May;58(Pt 5):554-62. doi: 10.1099/jmm.0.007724-0.

16.

Sero-characterization of lipopolysaccharide from Burkholderia thailandensis.

Qazi O, Prior JL, Judy BM, Whitlock GC, Kitto GB, Torres AG, Estes DM, Brown KA.

Trans R Soc Trop Med Hyg. 2008 Dec;102 Suppl 1:S58-60. doi: 10.1016/S0035-9203(08)70016-6.

17.

Host immunity in the protective response to vaccination with heat-killed Burkholderia mallei.

Whitlock GC, Lukaszewski RA, Judy BM, Paessler S, Torres AG, Estes DM.

BMC Immunol. 2008 Sep 29;9:55. doi: 10.1186/1471-2172-9-55.

18.

Alpha-beta T cells provide protection against lethal encephalitis in the murine model of VEEV infection.

Paessler S, Yun NE, Judy BM, Dziuba N, Zacks MA, Grund AH, Frolov I, Campbell GA, Weaver SC, Estes DM.

Virology. 2007 Oct 25;367(2):307-23. Epub 2007 Jul 5.

19.

Estrogen increases menopausal host susceptibility to experimental ascending urinary-tract infection.

Curran EM, Tassell AH, Judy BM, Nowicki B, Montgomery-Rice V, Estes DM, Nowicki S.

J Infect Dis. 2007 Mar 1;195(5):680-3. Epub 2007 Jan 18.

PMID:
17262709
20.

Estrogenic regulation of host immunity against an estrogen receptor-negative human breast cancer.

Curran EM, Judy BM, Duru NA, Wang HQ, Vergara LA, Lubahn DB, Estes DM.

Clin Cancer Res. 2006 Oct 1;12(19):5641-7. Epub 2006 Sep 25.

22.

Estrogen receptor-alpha deficiency promotes increased TNF-alpha secretion and bacterial killing by murine macrophages in response to microbial stimuli in vitro.

Lambert KC, Curran EM, Judy BM, Lubahn DB, Estes DM.

J Leukoc Biol. 2004 Jun;75(6):1166-72. Epub 2004 Mar 12.

PMID:
15020652
23.

Dietary soy phytoestrogens and ERalpha signalling modulate interferon gamma production in response to bacterial infection.

Curran EM, Judy BM, Newton LG, Lubahn DB, Rottinghaus GE, Macdonald RS, Franklin C, Estes DM.

Clin Exp Immunol. 2004 Feb;135(2):219-25.

24.

In vitro and in vivo regulation of antioxidant response element-dependent gene expression by estrogens.

Ansell PJ, Espinosa-Nicholas C, Curran EM, Judy BM, Philips BJ, Hannink M, Lubahn DB.

Endocrinology. 2004 Jan;145(1):311-7. Epub 2003 Oct 9.

PMID:
14551226
25.

Bisphenol A is released from used polycarbonate animal cages into water at room temperature.

Howdeshell KL, Peterman PH, Judy BM, Taylor JA, Orazio CE, Ruhlen RL, Vom Saal FS, Welshons WV.

Environ Health Perspect. 2003 Jul;111(9):1180-7.

26.

Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity.

Welshons WV, Thayer KA, Judy BM, Taylor JA, Curran EM, vom Saal FS.

Environ Health Perspect. 2003 Jun;111(8):994-1006. Review.

27.

Biocompatibility of hydroxylated metabolites of BISGMA and BFDGE.

Kostoryz EL, Eick JD, Glaros AG, Judy BM, Welshons WV, Burmaster S, Yourtee DM.

J Dent Res. 2003 May;82(5):367-71.

PMID:
12709503
28.

Gender, exercise training, and eNOS expression in porcine skeletal muscle arteries.

Laughlin MH, Welshons WV, Sturek M, Rush JW, Turk JR, Taylor JA, Judy BM, Henderson KK, Ganjam VK.

J Appl Physiol (1985). 2003 Jul;95(1):250-64. Epub 2003 Mar 7.

29.

Selective inhibition of murine palatal mesenchymal cell proliferation in vitro by secalonic acid D.

Hanumegowda UM, Judy BM, Welshons WV, Reddy CS.

Toxicol Sci. 2002 Mar;66(1):159-65.

PMID:
11861983
30.

Low-dose bioactivity of xenoestrogens in animals: fetal exposure to low doses of methoxychlor and other xenoestrogens increases adult prostate size in mice.

Welshons WV, Nagel SC, Thayer KA, Judy BM, Vom Saal FS.

Toxicol Ind Health. 1999 Jan-Mar;15(1-2):12-25.

PMID:
10188188
31.

Nuclear vs translocating steroid receptor models and the excluded middle.

Welshons WV, Judy BM.

Endocrine. 1995 Jan;3(1):1-4. doi: 10.1007/BF02917441. No abstract available.

PMID:
21153229
32.

Subcellular compartmentalization of MCF-7 estrogen receptor synthesis and degradation.

Welshons WV, Grady LH, Judy BM, Jordan VC, Preziosi DE.

Mol Cell Endocrinol. 1993 Aug;94(2):183-94.

PMID:
8224522
33.

Control of proliferation of MCF-7 breast cancer cells in a commercial preparation of charcoal-stripped adult bovine serum.

Welshons WV, Grady LH, Engler KS, Judy BM.

Breast Cancer Res Treat. 1992;23(1-2):97-104.

PMID:
1446058

Supplemental Content

Support Center